ASPEN PARK PHARMACEUTICALS, INC. — Form D
ASPEN PARK PHARMACEUTICALS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-10. The offering totals $20.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2014-10-10
- Form: D
- Accession: 0001620965-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Remaining: $20.0M
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-226229
Issuer
- Name: ASPEN PARK PHARMACEUTICALS, INC.
- CIK: 0001620965
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 944 PARK AVENUE, NEW YORK, NY, 10028
- Phone: 914-552-2651
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Harry S Fisch, MD | Director | New York, NY |
| Harry S Fisch, MD | Executive Officer | New York, NY |
| Mitchell S Steiner | Director | Chicago, IL |
| Mitchell S Steiner | Executive Officer | Chicago, IL |
| Harry S Fisch, M.D. | Director | New York, NY |
| Harry S Fisch, M.D. | Executive Officer | New York, NY |
Other filings by this issuer (1)
More